Midkine Symposium April 2016: Role of Midkine in brain tumours




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Midkine Symposium April 2016: Role of Midkine in brain tumours
Released on: June 27, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Professor Guillermo Velasco, Associate Professor of Biochemistry and Molecular Biology (Complutense University, Madrid, Spain), explains how blocking midkine signaling could facilitate the treatment of aggressive cancers including glioblastoma.
  • Summary
  • Transcript
  • Participants
  • Company
Professor Guillermo Velasco, Associate Professor of Biochemistry and Molecular Biology (Complutense University, Madrid, Spain), explains how blocking midkine signaling could facilitate the treatment of aggressive cancers including glioblastoma.
Professor Guillermo Velasco, Associate Professor of Biochemistry and Molecular Biology (Complutense University, Madrid, Spain), explains how blocking midkine signaling could facilitate the treatment of aggressive cancers including glioblastoma.
Guillermo Velasco
School of Biology, Complutense University, Madrid, Spain